Correction To: Real-world Characteristics, Treatment Experiences and Corticosteroid Utilisation of Patients Treated with Tofacitinib for Moderate to Severe Ulcerative Colitis
Overview
Overview
Journal
BMC Gastroenterol
Publisher
Biomed Central
Specialty
Gastroenterology
Date
2022 Jul 26
PMID
35883049
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Chiorean M, Allegretti J, Sharma P, Chastek B, Salese L, Bell E
. Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis. BMC Gastroenterol. 2022; 22(1):177.
PMC: 8994921.
DOI: 10.1186/s12876-022-02215-y.
View